multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-26 18:56 (3807 d 16:16 ago) – Posting: # 15858
Views: 5,200

❝ Please share your thoughts on that.


I've done a few of those IR/XR or IR/ER bilayer tablets before and emesis was be based on IR. It's one tablet for administration. Why would you based on MR for emesis dropout criteria?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
248 visitors (0 registered, 248 guests [including 8 identified bots]).
Forum time: 12:12 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5